WO2014094375A1 - Composition de venin d'abeille avec un effet d'élimination de l'acné - Google Patents
Composition de venin d'abeille avec un effet d'élimination de l'acné Download PDFInfo
- Publication number
- WO2014094375A1 WO2014094375A1 PCT/CN2013/070940 CN2013070940W WO2014094375A1 WO 2014094375 A1 WO2014094375 A1 WO 2014094375A1 CN 2013070940 W CN2013070940 W CN 2013070940W WO 2014094375 A1 WO2014094375 A1 WO 2014094375A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bee venom
- polysaccharide
- acne
- composition
- bee
- Prior art date
Links
- 239000003659 bee venom Substances 0.000 title claims abstract description 233
- 239000000203 mixture Substances 0.000 title claims abstract description 128
- 230000000694 effects Effects 0.000 title claims abstract description 69
- 206010000496 acne Diseases 0.000 title abstract description 126
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract description 122
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 28
- 239000002537 cosmetic Substances 0.000 claims abstract description 26
- 239000012528 membrane Substances 0.000 claims abstract description 11
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 11
- 229920001282 polysaccharide Polymers 0.000 claims description 87
- 239000005017 polysaccharide Substances 0.000 claims description 87
- 150000004676 glycans Chemical class 0.000 claims description 84
- 239000000843 powder Substances 0.000 claims description 46
- 241001474374 Blennius Species 0.000 claims description 25
- -1 carrageenan polysaccharide Chemical class 0.000 claims description 24
- 241000195493 Cryptophyta Species 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 241000195474 Sargassum Species 0.000 claims description 8
- 230000003255 anti-acne Effects 0.000 claims description 8
- 230000001815 facial effect Effects 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 240000002900 Arthrospira platensis Species 0.000 claims description 6
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 6
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 6
- 229940082787 spirulina Drugs 0.000 claims description 6
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical group CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 5
- 239000002502 liposome Substances 0.000 claims description 5
- 235000010413 sodium alginate Nutrition 0.000 claims description 5
- 239000000661 sodium alginate Substances 0.000 claims description 5
- 229940005550 sodium alginate Drugs 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- 241000195480 Fucus Species 0.000 claims description 4
- 235000010418 carrageenan Nutrition 0.000 claims description 4
- 239000000679 carrageenan Substances 0.000 claims description 4
- 229920001525 carrageenan Polymers 0.000 claims description 4
- 229940113118 carrageenan Drugs 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 239000010949 copper Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 241001428166 Eucheuma Species 0.000 claims description 3
- 241001261506 Undaria pinnatifida Species 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 claims 2
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 claims 2
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 claims 1
- 241000206672 Gelidium Species 0.000 claims 1
- 229920001543 Laminarin Polymers 0.000 claims 1
- 239000005717 Laminarin Substances 0.000 claims 1
- 241000219991 Lythraceae Species 0.000 claims 1
- 235000015110 jellies Nutrition 0.000 claims 1
- 239000008274 jelly Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 42
- 239000011701 zinc Substances 0.000 description 31
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 28
- 229910052725 zinc Inorganic materials 0.000 description 28
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 24
- LKLYETYHDMXRAF-UHFFFAOYSA-N 2-octanoyloxybenzoic acid Chemical compound CCCCCCCC(=O)OC1=CC=CC=C1C(O)=O LKLYETYHDMXRAF-UHFFFAOYSA-N 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 238000003756 stirring Methods 0.000 description 20
- 239000008367 deionised water Substances 0.000 description 19
- 229910021641 deionized water Inorganic materials 0.000 description 19
- 150000002148 esters Chemical class 0.000 description 19
- 230000003902 lesion Effects 0.000 description 16
- 230000002757 inflammatory effect Effects 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 239000002504 physiological saline solution Substances 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 9
- 210000003780 hair follicle Anatomy 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 231100000241 scar Toxicity 0.000 description 9
- 230000028327 secretion Effects 0.000 description 9
- 201000004624 Dermatitis Diseases 0.000 description 8
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- 239000004359 castor oil Substances 0.000 description 8
- 235000019438 castor oil Nutrition 0.000 description 8
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 8
- 230000004054 inflammatory process Effects 0.000 description 8
- 239000011148 porous material Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 7
- 208000032544 Cicatrix Diseases 0.000 description 7
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 7
- 229960005323 phenoxyethanol Drugs 0.000 description 7
- 230000037387 scars Effects 0.000 description 7
- 210000001732 sebaceous gland Anatomy 0.000 description 7
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 102000011782 Keratins Human genes 0.000 description 6
- 108010076876 Keratins Proteins 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 230000019612 pigmentation Effects 0.000 description 6
- 230000008439 repair process Effects 0.000 description 6
- 241000256844 Apis mellifera Species 0.000 description 5
- 101000761020 Dinoponera quadriceps Poneritoxin Proteins 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 240000007711 Peperomia pellucida Species 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 210000005069 ears Anatomy 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 241000512259 Ascophyllum nodosum Species 0.000 description 4
- 241000206607 Porphyra umbilicalis Species 0.000 description 4
- 206010037888 Rash pustular Diseases 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000001151 other effect Effects 0.000 description 4
- 208000029561 pustule Diseases 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- 241001635598 Enicostema Species 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 241000612166 Lysimachia Species 0.000 description 3
- 108010036176 Melitten Proteins 0.000 description 3
- 206010027626 Milia Diseases 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 210000001339 epidermal cell Anatomy 0.000 description 3
- 239000000413 hydrolysate Substances 0.000 description 3
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 206010000503 Acne cystic Diseases 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 235000003826 Artemisia Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000186427 Cutibacterium acnes Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010039580 Scar Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000009736 adult acne Diseases 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 244000030166 artemisia Species 0.000 description 2
- 235000009052 artemisia Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 150000003943 catecholamines Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000006749 inflammatory damage Effects 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- KONVNJDNYREFLP-UHFFFAOYSA-N octanoyl 2-hydroxybenzoate Chemical compound CCCCCCCC(=O)OC(=O)C1=CC=CC=C1O KONVNJDNYREFLP-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036555 skin type Effects 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 231100001274 therapeutic index Toxicity 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- PZEUTLIKVUEDLB-UHFFFAOYSA-N 2-[[[2-[[6-amino-2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[2-[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[2-[[2-[[2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]acetyl]amino]propanoylamino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]propanoylamino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-(carbamoylamino)propanoyl]-(3-amino-3-oxopropyl)carbamoyl]amino]pentanediamide Chemical compound CCC(C)C(NC(=O)CN)C(=O)NCC(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CNC(N)=O)C(=O)N(CCC(N)=O)C(=O)NC(CCC(N)=O)C(N)=O PZEUTLIKVUEDLB-UHFFFAOYSA-N 0.000 description 1
- KKOWXJFINYUXEE-UHFFFAOYSA-N 2-butoxyphenol Chemical compound CCCCOC1=CC=CC=C1O KKOWXJFINYUXEE-UHFFFAOYSA-N 0.000 description 1
- VSDNNWKISVRDNT-UHFFFAOYSA-N 2-octoxybenzoic acid Chemical compound CCCCCCCCOC1=CC=CC=C1C(O)=O VSDNNWKISVRDNT-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000037365 barrier function of the epidermis Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002910 effect on acne Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229940066369 honey bee venom Drugs 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002165 photosensitisation Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 230000036619 pore blockages Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000191 radiation effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Definitions
- the invention belongs to the field of cosmetics, and particularly relates to a bee venom composition having acne effect. Background technique:
- Acne is a common chronic hair follicle sebaceous gland inflammatory disease, which occurs in areas with strong sebum secretion such as the face, chest and upper back. It has a long course of disease and is prone to recurrence. It is often manifested as whitehead acne, blackhead acne or inflammatory papules. Serious pustules, nodules, cysts or scars. If the inflammation is obvious, it will cause pain or pain, accompanied by seborrhea, and even orange peel.
- the incidence of acne in young men and women is extremely high. It not only seriously affects the beauty of the face, but also affects the social and psychological aspects of the person, causing negative emotions such as distrust, embarrassment, loss, anxiety, nervousness, irritability and depression. Thereby affecting the quality of life.
- the cosmetics for treating acne on the market are often added with chemical fungicides, hormones, astringents and anti-inflammatory agents. Although they can be sterilized or anti-inflammatory in a short time, they are irritating to the skin, and long-term use will increase the burden on the skin. And cause allergic symptoms such as redness, suppuration or pain in the skin, and because the pathogen is highly susceptible to drug resistance, the acne will soon recur and form scars or pigmentation. Antibiotics and hormonal substances have been banned by the Cosmetic Hygiene Code (2007 Edition) due to long-term side effects.
- the object of the present invention is to provide a safer and lasting acne-producing effect against the problems of irritating acne cosmetics, skin allergies, and easy to leave dark marks and smells in Chinese medicine acne cosmetics.
- the bee venom composition, the bee venom composition has clear efficacy ingredients, stable quality, no toxic and side effects, does not cause skin allergy, does not leave scars or pigmentation after acne cure, and is not easy to relapse after being stopped.
- the bee venom composition having acne effect of the present invention comprises a acne cosmetic matrix component characterized by further containing bee venom.
- the bee venom is prepared by the following method, and the crude bee venom is dissolved in water, and then ultrafiltered through an ultrafiltration membrane with a molecular weight cut off of 1000OOD, and the filtrate is freeze-dried to obtain bee venom.
- the bee venom purification method simplifies the bee venom purification process, saves the cost, and can effectively enrich and concentrate the active substances such as melittin and bee venom peptide which have significant cosmetic skin care effects, and remove hyaluronic acid. Enzymes, phospholipase A 2 and other substances that cause skin allergies, inflammation and pain, while ensuring safety, no skin irritation and allergies, significantly enhance the efficacy of acne.
- the purification method solves the problems that the active substance having the beauty and skin care effect in the bee venom has not been effectively enriched in the prior art, fills the blank application of the bee venom in the acne cosmetics, and fully exerts its acne effect.
- the bee venom is present in an amount of 0.00001% to 2% of the total mass of the bee venom composition.
- the bee venom is preferably prepared by the following method: taking crude bee venom and adding 10-30 times volume of water to fully dissolve, centrifuging 5000-1000 g for 10-30 min, and the supernatant is ultrafiltered through an ultrafiltration membrane with a molecular weight cut off of 100OODa. Thereafter, the filtrate was freeze-dried to obtain bee venom.
- the bee venom composition having acne effect of the present invention preferably further contains seaweed polysaccharide and pearl powder, and the content of seaweed polysaccharide accounts for 0.01% of the total mass of the bee venom composition. 5%, the content of pearl powder accounts for 0.2%-15% of the total mass of the bee venom composition.
- the seaweed polysaccharide refers to sodium alginate, laver polysaccharide, wakame polysaccharide, pearl vegetable polysaccharide, broccoli polysaccharide, Eucheuma polysaccharide, Sargassum polysaccharide, kelp polysaccharide, Artemisia polysaccharide, Spirulina polysaccharide, Sargassum polysaccharide, A combination of one or more of a copper algae polysaccharide, a Fucus polysaccharide, a carrageenan polysaccharide, a big leaf algae polysaccharide, and a chlorella polysaccharide. It is commercially available and can also be prepared according to existing methods.
- the pearl powder of the present invention refers to a combination of one or more of nano pearl powder, water soluble pearl powder, and pearl hydrolyzate liposome. It is commercially available and can also be prepared according to existing methods.
- the bee venom composition having acne effect of the present invention may preferably contain PCA zinc and octanoylsalicylic acid, and the content of PCA zinc accounts for 0.01% of the total mass of the bee venom composition. %-1.5%, the content of octanoylsalicylic acid is from 0.1% to 2% of the total mass of the bee venom composition.
- PCA zinc, octanoylsalicylic acid and cosmetic bases of the present invention are all commercially available.
- the crude bee venom may be crude bee venom and/or bee crude bee venom, which may be collected by a bee venom collector or purchased from the market.
- the venom-promoting bee venom composition of the present invention is prepared by the following method, and the bee venom is prepared in powder form or pre-formed into a 10%-50% aqueous solution, and is homogenized or mixed with other ingredients. It can be formulated according to the conventional process according to the type of acne cosmetics formulated, and can be made into acne cosmetics such as cream, lotion, liquid, gel, gel or mask.
- the bee venom composition having the acne effect of the invention has good stability, uniform coating and good spreadability.
- the experimental results of animal experiments and human trials prove that the bee venom composition with acne effect of the invention is safe, non-irritating or photo-sensitizing to the skin, can effectively prevent and reduce the damage of ultraviolet rays to the skin, and can also sterilize and reduce inflammation. Moisturizes, balances oil secretion, and improves skin's self-protection.
- the bee venom composition having the acne effect of the present invention can be used as a general cosmetic or a functional cosmetic having an acne action.
- the solution of the present invention is based on the inventors' understanding of the conditions, pathogenesis, prevention and treatment methods of acne, and the beauty and skin care effects of functional active substances, combined with the research achievements of modern acne cosmetics and pharmacology, from among many functional active substances.
- Zinc and octanoyl salicylic acid through scientifically organized, make them play their own synergies:
- the bee venom in the bee venom composition having the acne effect of the invention is rich in active components such as melittin, bee venom peptide, catecholamine, free amino acid, vitamin, trace element and glycerin, and has small molecular weight and low immunogenicity. Not susceptible to allergic reactions.
- Melittin can effectively inhibit the proliferation of bacteria and fungi such as Propionibacterium acnes, Escherichia coli, Pseudomonas aeruginosa, Streptococcus and Staphylococcus aureus, reduce the skin's inflammatory response to acne, and has an analgesic effect. It also has significant anti-oxidation, anti-ultraviolet radiation and other effects.
- the bee venom peptide can improve the microcirculation, promote the synthesis of elastic fibers and collagen in the dermis, restore skin tension and elasticity, and promote the rapid closure of acne, repair existing sputum or prevent the formation of dark sputum.
- Catecholamine has an anti-inflammatory effect on damaged skin caused by acne, light, etc., and can reduce the formation of acne scars.
- Active substances such as free amino acids, vitamins and trace elements can provide nutrition to the skin, effectively prevent UV rays from causing damage to acne and form pigmentation, improve keratin metabolism, prevent hyperkeratosis of hair follicles, enhance epidermal barrier function, and reduce water loss.
- Reduce air pollution to skin, regulate skin permeability have antioxidant and promote skin self-repair.
- Glycerin maintains moisture in the skin, reduces sebaceous gland secretion, and promotes the penetration of other active ingredients into the deeper layers of the skin, helping to improve the skin's ability to repair itself.
- the seaweed polysaccharide in the bee venom composition having the acne effect of the invention has strong moisturizing property and can soften It exfoliates and acts as a broad-spectrum bactericidal effect by dissolving the bacterial inner membrane. It also scavenges free radicals, prevents skin lipid peroxidation, resists UV-induced skin damage, and repairs damaged cells and reduces pigmentation. Seaweed polysaccharide can also accelerate the transdermal absorption of acne active ingredients, thereby improving the acne effect.
- the pearl powder in the bee venom composition having the acne effect of the invention contains amino acids such as glycine, methionine and the like which promote the regeneration of skin collagen and trace elements such as Zn, which are easily absorbed by the human body and have bactericidal and anti-inflammatory effects. Detoxification, remove acne marks and other effects. Pearl powder can also promote epidermal cell regeneration and wound healing, so that impurities such as dust, oil stains, bacteria, peeling and dead cells in the pores of the skin can be smoothly discharged, making the skin smooth, white and moist, and effective against bee venom. Has a significant synergy.
- the PCA zinc in the bee venom composition having the acne effect of the present invention replaces the sodium ion thereof with a zinc ion having a bacteriostatic action, and can effectively inhibit P. acnes, Escherichia coli, Pseudomonas aeruginosa, Streptococcus and gold.
- the proliferation of bacteria and fungi such as Staphylococcus aureus, and excellent moisturizing effect.
- Zinc can regulate the sebaceous gland secretion and prevent hyperkeratosis of the hair follicle by inhibiting 5-ct reductase, thereby maintaining the oil-water balance of the skin.
- DNA synthesis, protein synthesis, cell division, and the maintenance of multiple enzyme activities in human tissues are inseparable from Zn, so supplementing the skin with Zn helps maintain normal skin metabolism, promotes epidermal cell growth and wound healing, and reduces Skin allergies.
- the octanoylsalicylic acid in the bee venom composition having the acne effect of the invention has a fat-soluble property and a large molecular weight, and can penetrate into the stratum corneum and the deep pores through the sebaceous glands which secrete oil by way of fusion with the lipid. Dissolve the angle plug, break down the keratin and dead skin that block the sebaceous glands and pores, improve the pore blockage, block the formation of acne, reduce or inhibit the symptoms of inflammation, remove the blackheads in the pores, and reduce the enlarged pores. It locks the action in the stratum corneum without affecting the active epidermal cells and dermal tissue. It has good stability, low irritation to the skin, and a low cumulative rate of irritation and inflammation. Salicylic acid also stimulates cell renewal and wound healing to improve skin tone, eliminate acne marks, and rejuvenate the skin.
- the present invention has the following beneficial effects:
- the bee venom composition having the acne effect of the present invention is selected from the pure natural bee venom as the main raw material for the specific physiological structure of the skin and its sensitivity to the ingredients used in cosmetics.
- bee venom has long been included in the "International Cosmetic Raw Materials Standard Chinese Name List (2010 Edition)", which shows that the application of bee venom to cosmetics is safe and feasible.
- the bee venom used is purified, and the substance which is easy to cause skin allergy, inflammation and pain in the crude bee venom is effectively removed, and the bee venom peptide is used.
- bee venom peptide and other ingredients Highly enriched to give a more pronounced acne effect.
- the bee venom composition having the acne effect of the present invention can be quickly absorbed by the skin, does not cause skin irritation, and does not impose any burden on the skin.
- the bee venom composition having the acne effect of the present invention secretes oil secretion, dissolves angle plugs, inhibits bacterial proliferation, repairs scars, resists ultraviolet rays, anti-inflammatory, anti-allergic, anti-oxidation, moisturizing, anti-inflammatory pigmentation, and promotes phlegm.
- the acne component is absorbed through the skin and promotes the healing of acne wounds. It exerts a comprehensive and significant acne effect, which restores the skin to normal, smooth and smooth. After discontinuation, symptoms such as acne are not easy to relapse, and acne is effective, long-lasting, and safe.
- the bee venom composition with acne effect of the invention adopts pure natural bee venom, has good compatibility with skin, can be quickly absorbed by the skin, is safe and mild, does not cause irritation, allergic reaction, and has no skin. burden.
- the bee venom composition with acne effect of the invention can synergistically synergize with bee venom, seaweed polysaccharide, pearl powder, and bee venom with PCA zinc and octanoyl salicylic acid to simultaneously clear pores, balance oil secretion, and sterilize , anti-inflammatory, anti-acne marks, moisturizing, sunscreen and other effects, to comprehensively repair and improve the barrier function of the skin, completely eliminate acne.
- the bee venom composition having the acne effect of the present invention is particularly effective for the healing of inflammatory lesions, pustules and cystic acne.
- the bee venom composition having the acne effect of the present invention is particularly effective for the healing of blackhead acne, whitehead acne, punctiform, papular and atrophic acne.
- the bee venom composition having the acne effect of the invention has various varieties and can meet the needs of different genders, ages and skin types of people suffering from problems such as acne, adult acne, acne marks or scars. detailed description:
- the bee venom collector was used to collect the crude bee venom of the wasp, dissolved in 25 times volume of water, centrifuged at 8000 g for 15 min, and the supernatant was ultrafiltered through an ultrafiltration membrane with a molecular weight cut off of 100 °D, and the filtrate was freeze-dried to obtain bee venom.
- the bee venom composition having the acne effect of the present embodiment is composed of the following components in a total mass percentage of 100%: Phase A: carbomer 0.1%, NaC 10.8%, 1,3-butanediol 5%, propylene glycol 4%, EDTA-2Na 0.1%, deionized water balance.
- Phase B 3% of fatty alcohol polyoxyethylene ether, 9% of C 12 -C 15 alkyl benzoate, 2% dioctyl carbonate, 0.8% microcrystalline wax, azone/PEG-40 hydrogenated castor oil 0.2% , Hansheng gum 0.5%.
- Phase C Bee venom 0.5% (prepared with deionized water in the form of a 50% bee venom solution).
- Phase D 0.5% parabens and 0.2% green tea flavor.
- the emulsion prepared in the embodiment has a fine hand feeling, uniform coating, no separation of oil and water, and easy absorption.
- Example 2
- the supernatant was ultrafiltered through an ultrafiltration membrane with a molecular weight cut off of 100 °D, and the filtrate was freeze-dried to obtain bee venom.
- the bee venom composition having the acne effect of the present embodiment is composed of the following components in a total mass percentage of 100%:
- Phase A Carbomer 0.2%, glycerin 4%, propylene glycol 3%, deionized water balance.
- Phase B cetearyl ether-21 2%, jojoba oil 3%, cetearyl alcohol 2%, glyceryl monostearate 1%, caprylic/capric triglyceride 4%, palmitic acid Ethylhexyl ester 3%, polydimethylsiloxane 2%, isopropyl myristate 3%, hydroxyphenylethyl ester 0.1%.
- Phase C Bee venom 0.00001% (added as a powder).
- Phase D Azone/PEG-40 hydrogenated castor oil 1%, triethanolamine 0.2%, phenoxyethanol/hydroxybenzyl ester/hydroxyphenylbutyl ester/hydroxyphenylethyl ester/hydroxypropylpropyl ester/hydroxyphenyl isobutyl ester 0.1 %.
- Phase D mixed and homogenized to prepare the bee venom composition having the acne effect of the present embodiment, a acne cream containing bee venom Frost.
- the cream prepared in the embodiment has a luster, a fine texture, a uniform distribution, and no separation of the oil and water phases.
- Bee bee venom was collected by bee venom collector, dissolved in 30 times volume of water, centrifuged lOOmin for lOmin, and the supernatant was ultrafiltered by ultrafiltration membrane with molecular weight cut off of 100OODa. The filtrate was freeze-dried to obtain bee venom.
- the bee venom composition having the acne effect of the present embodiment is composed of the following components in a total mass percentage of 100%:
- Phase A glycerol 5%, propylene glycol 3%, butanediol 2%, deionized water balance.
- Phase B Beeswax bee venom 1%, bee venom 1% (bee venom is added in the form of powder), deionized water 38%.
- Phase C Azone/PEG-40 hydrogenated castor oil 1%, triethanolamine 0.2%, phenoxyethanol/hydroxybenzyl ester/hydroxyphenylbutyl ester/hydroxyphenylethyl ester/hydroxypropylpropyl ester/hydroxyphenyl isobutyl ester 0.1 %.
- Process 30 ° C, first mix phase A, then add pre-mixed phase B to phase A, stir and mix evenly, add phase C component, mix and prepare the bee venom with acne effect of this example
- the composition one contains a bee venom acne agent.
- the aqueous preparation prepared by the embodiment has no precipitation, high transparency, easy absorption, and no irritation.
- Example 4
- the bee venom composition having the acne effect of the present embodiment is composed of the following components in a total mass percentage of 100%:
- Phase A 0.4% of butyl rubber, 0.6% of acrylate/C 1Q _ 3Q alkyl acrylate cross-linked polymer, EDTA-2Na 0.1% glycerin 5%, propylene glycol 5%, butanediol 5%, deionized water balance.
- Phase B Bee venom 0.5% (prepared in the form of distilled water pre-formed into a mass fraction of 10% bee venom solution), kelp polysaccharide 0.01%, pearl hydrolysate liposome 3%, deionized water 20%.
- Phase C PEG-40 hydrogenated castor oil ester 1%, triethanolamine 0.2%, fragrance 0.1%, phenoxyethanol / methylparaben / hydroxyphenyl butyl ether / hydroxyphenyl ethyl ester / hydroxypropyl propyl ester / hydroxybenzene butyl butyl Ester 0.1%.
- the acne-promoting bee venom composition contains a acne gel containing bee venom.
- the gel prepared in the present embodiment is transparent, finely organized, and free of agglomeration. There is no paste separation at -10 ° C and 40 ° C.
- the bee venom was prepared according to the method of preparing bee venom according to Example 1.
- the bee venom composition having the acne effect of the present embodiment is composed of the following components in a total mass percentage of 100%:
- Phase A Hansheng gum 0.2%, acrylate/C 1Q _ 3Q alkyl acrylate crosslinked polymer 0.6%, glycerin 5%, propylene glycol 3%, deionized water balance.
- Phase B Bee venom 0.00001% (added in the form of deionized water pre-formed into 10% bee venom solution), sodium alginate 1%, laver polysaccharide 0.5%, wakame polysaccharide 0.5%, Lysimachia polysaccharide 0.5%, Cauliflower polysaccharide 0.5%, Eucheuma polysaccharide 0.5%, Sargassum polysaccharide 0.5%, Artemisia polysaccharide 0.5%, Sargassum polysaccharide 0.5%, water-soluble pearl powder 0.2%, deionized water 30%.
- Phase C Azone/PEG-40 hydrogenated castor oil 1%, triethanolamine 0.3%, phenoxyethanol/hydroxybenzyl ester/hydroxyphenylbutyl ester/hydroxyphenylethyl ester/hydroxypropylpropyl ester/hydroxyphenyl isobutyl ester 0.1 %.
- the bee venom composition having the acne effect of the present embodiment is a acne gel containing bee venom.
- the gel prepared in the present embodiment is light in texture and cool.
- Example 6 The bee venom was prepared according to the method of preparing bee venom according to Example 2.
- the bee venom composition having the acne effect of the present embodiment is composed of the following components in a total mass percentage of 100%:
- Bee venom 2% (added in the form of powder), spirulina polysaccharide 0.2%, copper algae 0.2%, Fucus polysaccharide 0.2%, carrageenan 0.2%, big leaf algae 0.2%, chlorella polysaccharide 0.2 %, nano pearl powder 5%, water soluble pearl powder 10%, almond powder 11%, honey 5%, preservative 1%, deionized water balance.
- the bee venom, spirulina polysaccharide, copper algae polysaccharide, fucus polysaccharide, carrageenan polysaccharide, big leaf algae polysaccharide, chlorella polysaccharide, water-soluble pearl powder are dissolved in deionized water, and all dissolved, at room temperature Add the pre-mixed nano pearl powder and almond powder, stir and mix at 50r/m for 5min, add honey and preservative, stir and mix for 5min, and obtain the bee venom composition containing acne effect of this embodiment. Bee venom acne mask.
- the bee venom was prepared according to the method of preparing bee venom according to Example 3.
- the bee venom composition having the acne effect of the present embodiment is composed of the following components in a total mass percentage of 100%:
- Phase A Carbomer 0.1%, glycerol 5%, propylene glycol 3%, deionized water balance.
- Phase B 1% octanoylsalicylic acid, 1.2% of cetearyl ether-2, 1.5% of cetearyl ether-21, 3% of hydrogenated polyisobutylene, 3% of caprylic/capric triglyceride, Ethylhexyl palmitate 3%, polydimethylsiloxane 2%, and hydroxyethyl ester 0.1%.
- Phase C Bee venom 0.5% (pre-formed with deionized water in the form of 50% bee venom solution), PCA zinc 0.5%, deionized water 20%.
- Phase D Azone/PEG-40 hydrogenated castor oil 1%, triethanolamine 0.1%, phenoxyethanol/hydroxybenzyl ester/hydroxyphenylbutyl ester/hydroxyphenylethyl ester/hydroxypropylpropyl ester/hydroxyphenyl isobutyl ester 0.1 %.
- the emulsion prepared in the embodiment has a fine hand feeling, uniform coating, no separation of oil and water, and easy absorption.
- the bee venom was prepared according to the method of preparing bee venom according to Example 1.
- the bee venom composition having the acne effect of the present embodiment is composed of the following components in a total mass percentage of 100%:
- Phase A glycerol 5%, propylene glycol 3%, butanediol 2%, deionized water balance.
- Phase B Bee venom 0.00001% (bee venom is added in the form of powder), PCA zinc 1.5%, deionized water 30%.
- Phase C 2% octanoyl salicylic acid, 1% azone/PEG-40 hydrogenated castor oil, 0.2% triethanolamine, phenoxyethanol/hydroxybenzyl ester/hydroxyphenylbutyl ester/hydroxyphenylethyl ester/hydroxyphenylpropyl Ester/hydroxyphenyl isobutyl ester 0.1%.
- Process 35 °C, first mix phase A, then add pre-mixed phase B to phase A, stir and mix evenly, add phase C component, mix and prepare the bee venom with acne effect of this example
- the composition one contains a bee venom acne agent.
- the aqueous preparation prepared by the embodiment has no precipitation, high transparency, easy absorption, and no irritation.
- Example 9
- the bee venom was prepared according to the method of preparing bee venom according to Example 4.
- the bee venom composition having the acne effect of the present embodiment is composed of the following components in a total mass percentage of 100%:
- Phase A xanthan gum 0.4%, acrylate/C 1Q _ 3Q alkyl acrylate crosslinked polymer 0.6%, EDTA-2Na 0.1% glycerin 5%, propylene glycol 5%, butanediol 5%, deionized water margin.
- Phase B Bee venom 2% (prepared in distilled water with 10% bee venom solution), PCA zinc 0.01%, deionized water 20%.
- Phase C octanoylsalicylic acid 0.1%, PEG-40 hydrogenated castor oil ester 1%, triethanolamine 0.2%, perfume 0.1%, phenoxyethanol/hydroxybenzyl ester/hydroxyphenylbutyl ester/hydroxyphenylethyl ester/hydroxyl Phenylpropyl ester / hydroxyphenyl isobutyl ester 0.1%.
- the acne-promoting bee venom composition contains a bee venom acne gel.
- the gel prepared in this embodiment is transparent, finely organized, and free of agglomeration. There is no paste separation at -10 ° C and 40 ° C.
- the percentages of this example refer to mass percentages.
- wasp bee venom and bee venom of this example were prepared in accordance with the preparation method of Example 3.
- Crude bee venom composition ie sample A, crude bee venom content is 2% by mass:
- Containing bee venom composition ie sample B, bee venom content is 2% by mass:
- seaweed polysaccharide and pearl powder composition Containing seaweed polysaccharide and pearl powder composition (ie sample C, total content of seaweed polysaccharide, pearl powder is 2% by mass):
- C3 spirulina polysaccharide 0.5%, big leaf algae polysaccharide 0.5%, chlorella polysaccharide 0.5%, water soluble pearl powder 0.5%, physiological saline 98%;
- C4 Laver polysaccharide 0.5%, Lysimachia polysaccharide 0.5%, Sargasso polysaccharide 0.5%, pearl hydrolysate liposome 0.5%, normal saline 98%.
- D3 honey bee venom 0.1%, spirulina polysaccharide 0.4%, big leaf algae polysaccharide 0.5%, chlorella polysaccharide 0.5%, water soluble pearl powder 0.5%, physiological saline 98%;
- D4 Wasp bee venom 1%, laver polysaccharide 0.2%, Lysimachia polysaccharide 0.2%, Sargassum polysaccharide 0.1%, pearl hydrolysate liposome 0.5%, physiological saline 98%.
- composition containing PCA zinc and octanoyl salicylic acid ie sample E, total content of PCA zinc and octanoyl salicylic acid
- E2 PCA zinc 1.5%, octanoyl salicylic acid 0.5%, physiological saline 98%.
- Composition containing bee venom, PCA zinc and octanoyl salicylic acid ie sample F, total content of bee venom, PCA zinc and octanoyl salicylic acid is 2% by mass
- F1 wasp bee venom 0.5%, PCA zinc 1%, octanoyl salicylic acid 0.5%, physiological saline 98%;
- F2 bee venom 0.4%, wasp bee venom 0.4%, PCA zinc 1%, octanoyl salicylic acid 0.2%, physiological saline 98%.
- Example Cl-C4 bee venom, seaweed polysaccharide and pearl powder composition group (sample Dl-D4), PCA zinc and octanoyl salicylate composition group (sample El-E2), containing bee venom, PCA Zinc and octanoyl salicylate composition groups (samples F1-F2), 6 in each group.
- Corresponding samples were applied to the affected ears of rabbits in each group, about 0.5 mL each time, 3 times/d for 7 days. The therapeutic effect was observed day by day. After 7 days of the last application, the ear biopsy of the ear was taken at the ipsilateral ear and the histopathological changes were observed.
- Acid composition (ie F 2 6 1 5 100 sample F ) After 7 days of saline application, there was no significant change in acne, rough skin, and sensitive grain touch on the ears. The embolization of the hair follicles of rabbit ears was visible, and inflammatory cells were visible around the sebaceous glands. Infiltrated with nodules. Compared with the saline group, the AF of the sample was more effective in improving the acne of the rabbit ear.
- the bee venom-containing composition ie, sample B
- the bee venom-containing composition has no significant irritation and sensitization to the skin as compared to the crude bee venom composition (ie, sample A) due to the removal of the sensitizing source in the crude bee venom. Due to the enrichment of the active ingredients in bee venom, the bee venom composition has an improved effect on rabbit acne than the crude bee venom composition.
- composition containing bee venom ie sample B
- composition containing seaweed polysaccharide and pearl powder ie sample C
- composition containing bee venom, seaweed polysaccharide and pearl powder ie sample D
- composition containing bee venom, PCA zinc and octanoylsalicylic acid compared to the composition containing bee venom (ie sample B), containing PCA zinc and octanoylsalicylic acid (ie sample E)
- PCA zinc, octyl salicylic acid and bee venom in the present invention have significant synergistic effects.
- the bee venom composition having the acne effect of the present invention has a remarkable therapeutic effect on the rabbit ear acne model, and the drug can exhibit a remarkable effect after 4 days of administration.
- the bee venom composition having the acne effect prepared in Examples 1-9 was subjected to a human trial, and the samples 1-9 were in turn the bee venom compositions having the acne effect prepared in Examples 1-9.
- a total of 45 volunteers with mild and moderate facial acne were selected, including 15 males and 30 females; aged 17-35 years, mean 28.3 years; duration 4 weeks-7 years, average 3.5 years, before applying cosmetics 2 weeks, no glucocorticoids, retinoids and antibiotics, no hyperlipidemia and abnormal liver and kidney function, alcoholism is prohibited, and strong sunlight or ultraviolet radiation is avoided.
- Example 6 The method of using the mask prepared in Example 6 is: washing the face with warm water. For the part, apply the mask to the skin of the affected part for 10 minutes, then wash it with water, once a night for 4 weeks). Before treatment and at the 4th week of treatment, the total number of facial inflammatory lesions (sum of inflammatory papules and pustules) and the total number of non-inflammatory lesions (sum of whiteheads and blackheads) were counted separately, and detailed records were used. Adverse reactions.
- Ke Yu The efficacy index is ⁇ 90%; markedly effective: 60% ⁇ therapeutic index ⁇ 90%; progress: 20% ⁇ therapeutic index ⁇ 60%; invalid: efficacy index ⁇ 20%.
- Efficacy index (total number of lesions before treatment - total lesions after treatment) / total lesions before treatment x l00%.
- Effectiveness (base number of cases + number of effective cases) / number of cases ⁇ ⁇ %.
- Example 1 The therapeutic effect of the bee venom composition with acne effect on acne The more effective the sample base is, the more effective the total number of cases is. (%) Example 1 1 4 5 100 Example 2 5 5 100 Example 3 2 3 5 100 Example 4 2 3 5 100 Example 5 1 4 5 100 Example 6 3 2 5 100 Example 7 1 4 5 100 Example 8 1 3 1 5 80 Example 9 2 3 5 100
- the acne-promoting bee venom composition has good compatibility with the skin, can be quickly absorbed by the skin, safe and mild, does not cause irritation, allergies, etc., does not burden the skin, but also dissolves the angle plug, reduces inflammation, and promotes rapid wounds. Heal, repair scars, and reduce pigmentation.
- the bee venom composition prepared in Examples 1-3 (bee venom is the main acne component) cured 160 inflammatory lesions of the face, 258 non-inflammatory lesions; the bee venom composition prepared in Examples 4-6 ( Bee venom, seaweed polysaccharide and pearl powder are the main acne ingredients), 216 facial inflammatory lesions were cured, and 275 non-inflammatory lesions; bee venom compositions prepared in Examples 7-9 (bee venom, PCA zinc and octanoyl) Salicylic acid is the main acne component). It has cured 177 facial inflammatory lesions and 301 non-inflammatory lesions.
- the bee venom composition having the acne effect of the invention has the effects of reducing inflammation, sunscreen, moisturizing and acne scar, and is effective for curing inflammatory damage and pustules.
- sexual and cystic acne has obvious effects.
- the bee venom is compounded with PCA zinc and octanoylsalicylic acid, the bee venom composition having the acne effect of the invention significantly enhances the pores and balances the secretion of oil and the like, and is effective for curing non-inflammatory damage, spotting, The effect of papular and atrophic acne is obvious.
- the acne-promoting bee venom composition of the present invention is suitable for people of different genders, ages, and skin types suffering from problems such as acne, adult acne, acne scars, or scars.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne une composition de venin d'abeille ayant un effet d'élimination de l'acné qui comprend un composant de matrice et du venin d'abeille. Le venin d'abeille est préparé au moyen du procédé suivant : prélèvement de venin d'abeille brut, dissolution du venin d'abeille brut en utilisant de l'eau, mise en œuvre d'une ultrafiltration au moyen d'une membrane d'ultrafiltration avec un seuil de coupure de poids moléculaire de 10000 Da, et congélation et séchage de la liqueur de filtration, afin d'obtenir le venin d'abeille.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210563008.XA CN102988262B (zh) | 2012-12-20 | 2012-12-20 | 一种具有祛痘功效的蜂毒组合物 |
CN201210563008.X | 2012-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014094375A1 true WO2014094375A1 (fr) | 2014-06-26 |
Family
ID=47917697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2013/070940 WO2014094375A1 (fr) | 2012-12-20 | 2013-01-24 | Composition de venin d'abeille avec un effet d'élimination de l'acné |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102988262B (fr) |
WO (1) | WO2014094375A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109797180A (zh) * | 2019-01-14 | 2019-05-24 | 浙江工商大学 | 提高坛紫菜多糖生物活性的方法 |
WO2021022345A1 (fr) * | 2019-08-06 | 2021-02-11 | Natura Cosméticos S.A. | Composition cosmétique topique, utilisation de cette composition et tonique pour application faciale |
WO2024076330A1 (fr) * | 2022-10-05 | 2024-04-11 | Bilecik Seyh Edebali Universitesi | Composition à base d'exosome d'abeille ayant des propriétés antibiotiques contre la formation de biofilm et procédé de préparation de cette composition |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104906014A (zh) * | 2015-05-18 | 2015-09-16 | 台山市互信生物科技有限公司 | 一种蜂毒橄榄按摩油及其使用方法 |
CN105395407B (zh) * | 2015-12-01 | 2019-03-05 | 青岛中皓生物工程有限公司 | 以海洋材料为主的滢润防衰老精华液及滢润防衰老化妆品 |
CN106265283A (zh) * | 2016-08-30 | 2017-01-04 | 广州君恒生物科技有限公司 | 一种祛痘水 |
CN107049890B (zh) * | 2017-06-27 | 2020-04-03 | 广东芭薇生物科技股份有限公司 | 一种具有舒缓抗粉刺功效的护肤品 |
CN110151631A (zh) * | 2019-06-26 | 2019-08-23 | 广州三广生物科技有限公司 | 一种天然控油祛痘组合物 |
CN111249440A (zh) * | 2020-03-06 | 2020-06-09 | 暨南大学 | 小分子短肽在制备治疗痤疮的产品中的应用 |
CN111743830A (zh) * | 2020-06-19 | 2020-10-09 | 广州天玺生物科技有限公司 | 一种祛痘组合物及其应用 |
CN112353745A (zh) * | 2020-11-19 | 2021-02-12 | 李刚 | 蜂霜及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0970690A1 (fr) * | 1998-07-06 | 2000-01-12 | L'oreal | Composition cosmétique et/ou dermatologique contenant des dérivés d'acide salicylique et procédé d'introduction des dits dérivés dans une composition aqueuse |
CN101456837A (zh) * | 2009-01-07 | 2009-06-17 | 南京中狮化学品有限公司 | 一种吡咯烷酮羧酸锌的合成方法 |
KR20120038699A (ko) * | 2010-10-14 | 2012-04-24 | 주식회사 젠피아 | 봉독을 함유하는 여드름 치료 및 예방용 화장 조성물 |
CN102525864A (zh) * | 2012-01-05 | 2012-07-04 | 佛山科学技术学院 | 一种用于祛除青春痘的海洋生物功能化妆品 |
CN102548564A (zh) * | 2009-07-28 | 2012-07-04 | 农村振兴厅 | 用于预防和治疗痤疮的包含作为活性成分的蜂毒的组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1088215A (zh) * | 1992-12-14 | 1994-06-22 | 刘尽晖 | 从蜂毒中快速分离蜂肽的方法 |
-
2012
- 2012-12-20 CN CN201210563008.XA patent/CN102988262B/zh active Active
-
2013
- 2013-01-24 WO PCT/CN2013/070940 patent/WO2014094375A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0970690A1 (fr) * | 1998-07-06 | 2000-01-12 | L'oreal | Composition cosmétique et/ou dermatologique contenant des dérivés d'acide salicylique et procédé d'introduction des dits dérivés dans une composition aqueuse |
CN101456837A (zh) * | 2009-01-07 | 2009-06-17 | 南京中狮化学品有限公司 | 一种吡咯烷酮羧酸锌的合成方法 |
CN102548564A (zh) * | 2009-07-28 | 2012-07-04 | 农村振兴厅 | 用于预防和治疗痤疮的包含作为活性成分的蜂毒的组合物 |
KR20120038699A (ko) * | 2010-10-14 | 2012-04-24 | 주식회사 젠피아 | 봉독을 함유하는 여드름 치료 및 예방용 화장 조성물 |
CN102525864A (zh) * | 2012-01-05 | 2012-07-04 | 佛山科学技术学院 | 一种用于祛除青春痘的海洋生物功能化妆品 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109797180A (zh) * | 2019-01-14 | 2019-05-24 | 浙江工商大学 | 提高坛紫菜多糖生物活性的方法 |
CN109797180B (zh) * | 2019-01-14 | 2020-10-20 | 浙江工商大学 | 提高坛紫菜多糖生物活性的方法 |
WO2021022345A1 (fr) * | 2019-08-06 | 2021-02-11 | Natura Cosméticos S.A. | Composition cosmétique topique, utilisation de cette composition et tonique pour application faciale |
WO2024076330A1 (fr) * | 2022-10-05 | 2024-04-11 | Bilecik Seyh Edebali Universitesi | Composition à base d'exosome d'abeille ayant des propriétés antibiotiques contre la formation de biofilm et procédé de préparation de cette composition |
Also Published As
Publication number | Publication date |
---|---|
CN102988262B (zh) | 2014-08-20 |
CN102988262A (zh) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014094375A1 (fr) | Composition de venin d'abeille avec un effet d'élimination de l'acné | |
US5266318A (en) | Skin therapeutic mixture containing cold-processsed aloe vera extract, with yellow sap and aloin removed | |
CN108969446B (zh) | 一种增强皮肤屏障功能的婴幼儿防皴护肤组合物及其制备方法 | |
CN102525864B (zh) | 一种用于祛除青春痘的海洋生物功能化妆品 | |
CN103191042A (zh) | 祛斑美白防皱保湿抗过敏抗衰老护肤剂 | |
US20100105644A1 (en) | Botanical composition for enhanced skin repair and uses thereof | |
CN108186394A (zh) | 一种舒敏修护滋养面膜精华及制备方法 | |
CN111973508A (zh) | 一种舒缓保湿的抗初老组合物 | |
NZ535268A (en) | Composition for pain mediation and apparatus and method of use thereof | |
CN113018238A (zh) | 一种抑菌消炎清爽益肤的祛痘凝胶及其制备方法 | |
WO2014094377A1 (fr) | Composition de venin d'abeille ayant des effets de protection et d'embellissement des lèvres | |
WO2014094380A1 (fr) | Composition de venin d'abeille ayant un effet de résistance au soleil | |
CN108938511B (zh) | 天然植物提取物的组合物及在皮肤保湿祛痘产品中的应用 | |
CN104922008A (zh) | 一种除色斑精华素 | |
WO2015010372A1 (fr) | Crème pour le traitement de l'acné, de taches et l'éclaircissement de la peau | |
CN108938514B (zh) | 一种清肤祛痘液及其制备方法 | |
CN107441340B (zh) | 一种消肿止痛止痒滋养皮肤的手足皴裂膏及其制备方法 | |
CA2700335A1 (fr) | Composition comportant des polysaccharides mucilagineux derives de alde barbadensis combines a des liposomes, methode pour l'obtenir et utilisation de celle-ci comme ecran solaire, agent anti-acne, regenerateur d'epiderme ou hydratant | |
CN112870140A (zh) | 一种抗敏止痒组合物、护肤凝露及其制备方法、应用 | |
CN115671239B (zh) | 一种抗炎消肿抑菌止痒防裂修复的冻愈膏及其制备方法 | |
JP2005015375A (ja) | Alteromonasmacleodiiから得られる外分泌性ポリサッカライドを含有することを特徴とする皮膚外用剤 | |
US10780142B2 (en) | Aloe-hyplex topical formulation and a method of preparation | |
EP3458019A1 (fr) | Produit destiné au traitement et à la prévention des syndromes d'épuisement professionnel visibles au niveau du cuir chevelu et de la peau | |
JP3219401B1 (ja) | 殺菌作用を有する組成物、該組成物からなる化粧料及び紫外線遮断材 | |
JPH06509060A (ja) | 皮膚を処置するための治療用および化粧用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13865159 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13865159 Country of ref document: EP Kind code of ref document: A1 |